Avidity of anti-?2-glycoprotein I antibodies in patients with antiphospholipid syndrome
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F12%3A10120324" target="_blank" >RIV/00216208:11140/12:10120324 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1177/0961203312440057" target="_blank" >http://dx.doi.org/10.1177/0961203312440057</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/0961203312440057" target="_blank" >10.1177/0961203312440057</a>
Alternative languages
Result language
angličtina
Original language name
Avidity of anti-?2-glycoprotein I antibodies in patients with antiphospholipid syndrome
Original language description
Antibodies against ?(2)-glycoprotein I (anti-?(2)GPI) are one of the hallmarks of the antiphospholipid syndrome (APS). However, they are heterogenic regarding their epitope specificity, pathogenic mechanisms and their avidity. In the current study we present some outstanding issues about avidity of anti-?(2)GPI antibodies. Our results confirmed that high avidity anti-?(2)GPI are associated with thrombosis and APS, while in low avidity anti-?(2)GPI group non-APS (predominantly systemic lupus erythematosus) patients prevailed.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FK - Gynaecology and obstetrics
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lupus
ISSN
0961-2033
e-ISSN
—
Volume of the periodical
21
Issue of the periodical within the volume
7
Country of publishing house
GB - UNITED KINGDOM
Number of pages
2
Pages from-to
764-765
UT code for WoS article
000304454200023
EID of the result in the Scopus database
—